Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025)

Oramed Pharmaceuticals (ORMP) posted Minority Interest of -$952000.0 for Q3 2025, down 0.63% on a QoQ basis from -$946000.0 in Q2 2025, and down 3.59% year-over-year from -$987458.2 in Q3 2024.

Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025) Analysis & Trends

Oramed Pharmaceuticals' Minority Interest history runs 5 years deep, the most recent figure standing at -$952000.0 for Q3 2025.

  • Quarterly Minority Interest fell 3.59% year-over-year to -$952000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$952000.0 (down 3.59% YoY) and the FY2024 annual result came in at -$918000.0, up 1.08% from the prior year.
  • Minority Interest was -$952000.0 for Q3 2025 at Oramed Pharmaceuticals, down from -$946000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $1.1 million in Q2 2021 and bottomed at -$952000.0 in Q3 2025.
  • A 5-year average of -$542833.3 and a median of -$896500.0 in 2023 frame the typical range for Minority Interest.
  • Annual changes were most pronounced in 2023 — Minority Interest sank 552.38% — and 2024, when it advanced 1.08%.
  • Oramed Pharmaceuticals' Minority Interest stood at $536000.0 in 2021, then sank by 222.39% to -$656000.0 in 2022, then tumbled by 41.46% to -$928000.0 in 2023, then increased by 1.08% to -$918000.0 in 2024, then retreated by 3.7% to -$952000.0 in 2025.
  • Business Quant data shows ORMP's Minority Interest at -$952000.0 in Q3 2025, -$946000.0 in Q2 2025, and -$918000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Oramed Pharmaceuticals 170.25 Mn 170.25 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -952,000.00
Jun 30, 2025 -946,000.00
Mar 31, 2025 -918,000.00
Dec 31, 2024 -918,000.00
Sep 30, 2024 -919,000.00
Jun 30, 2024 -911,000.00
Mar 31, 2024 -918,000.00
Dec 31, 2023 -928,000.00
Sep 30, 2023 -902,000.00
Jun 30, 2023 -891,000.00
Mar 31, 2023 -822,000.00
Dec 31, 2022 -656,000.00
Sep 30, 2022 -661,000.00
Jun 30, 2022 -660,000.00
Mar 31, 2022 -126,000.00
Nov 30, 2021 536,000.00
Aug 31, 2021 744,000.00
May 31, 2021 1.08 Mn